Clinical significance of nuclear factor κB and chemokine receptor CXCR4 expression in patients with diffuse large B-cell lymphoma who received rituximab-based therapy

High Expression of CXCR4 and CXCR7 Predicts Poor Survival in Gallbladder Cancer

(2013) X Yao et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Treatment of Diffuse Large B Cell Lymphoma

(2012) Jae-Yong Kwak   KOREAN JOURNAL OF INTERNAL MEDICINE

Expression of CXCR4 indicates poor prognosis in patients with clear cell carcinoma of the ovary

(2011) Ryuichiro Sekiya et al.   HUMAN PATHOLOGY

Pathogenesis of Non-Hodgkin's Lymphoma

(2011) Hendrik Nogai et al.   JOURNAL OF CLINICAL ONCOLOGY

The biological and clinical impact of inhibition of NF-κB-initiated apoptosis in diffuse large B cell lymphoma (DLBCL)

(2011) Prashant Bavi et al.   JOURNAL OF PATHOLOGY

Evaluation of nuclear factor κB and chemokine receptor CXCR4 co-expression in patients with prostate cancer in the Radiation Therapy Oncology Group (RTOG) 8610

(2010) Meena Okera et al.   BJU INTERNATIONAL

Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma

(2009) Mara Compagno et al.   NATURE

Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF- B and JNK/AP-1 pathways

(2008) M. T. Scupoli et al.   HAEMATOLOGICA

Activation of the NF-κB signalling pathway in diffuse large B-cell lymphoma: clinical implications

(2008) I Espinosa et al.   HISTOPATHOLOGY

Recent prognostic factors in diffuse large B-cell lymphoma indicate NF-κB pathway as a target for new therapeutic strategies

(2008) Alessandro Pavan et al.   LEUKEMIA & LYMPHOMA